Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1180, doi. 10.1634/theoncologist.2019-0067
- By:
- Publication type:
- Article